Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022)

Literature Review: Effectivity of Complementary Therapies in Children with Acute Lymphoblastic Leukemia

Authors
Dera Alfiyanti1, *, Alfin Ni’mah Rosyada1, Mariyam1, Vivi Yosafianti Pohan1, Amin Samiasih1, Yuni Sufyanti Arief2
1Departemen of Nursing, Faculty of Nursing and Health Sciences, Universitas Muhammadiyah Semarang, Semarang, Indonesia
2Faculty of Nursing, Universitas Airlangga, Surabaya, Indonesia
*Corresponding author. Email: dera.alfiyanti@unimus.ac.id
Corresponding Author
Dera Alfiyanti
Available Online 26 December 2022.
DOI
10.2991/978-94-6463-070-1_26How to use a DOI?
Keywords
Children; Acute Lymphoblastic Leukemia (ALL); Complementary therapy
Abstract

Leukemia is a chronic disease that affects children's physiology, psychology, also their growth, and development. It also impacts children life quality. Acute lymphoblastic leukemia (ALL) disease and its chemotherapy give some effects on children. The effects can be reduced by the nurse through an atraumatic care intervention using implementing complementary therapies. The objective of this therapy is to improve and maintain children's life quality. The goal of this research is to describe the effectiveness of complementary therapies in children with ALL (Acute Lymphoblastic Leukemia). This study uses the literature review method by selecting some journal articles using the PICO technique. The exclusion-inclusion criteria in selecting the journal article are: published in the latest 5 years (2016–2021), used Indonesian and English language, available in the full-text format, and has a specific theme in complementary therapy for children with ALL. Based on the analysis of the articles, it is concluded that most of the interventions in therapy can reduce some symptoms because of ALL diseases and the side effect of chemotherapy. From this study, it is suggested that some successfully proven interventions can be applied and implemented independently by the family with ALL diseases children. It is also recommended to be used as a nursing care intervention in development centers/services.

Copyright
© 2022 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022)
Series
Advances in Health Sciences Research
Publication Date
26 December 2022
ISBN
10.2991/978-94-6463-070-1_26
ISSN
2468-5739
DOI
10.2991/978-94-6463-070-1_26How to use a DOI?
Copyright
© 2022 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Dera Alfiyanti
AU  - Alfin Ni’mah Rosyada
AU  - Mariyam
AU  - Vivi Yosafianti Pohan
AU  - Amin Samiasih
AU  - Yuni Sufyanti Arief
PY  - 2022
DA  - 2022/12/26
TI  - Literature Review: Effectivity of Complementary Therapies in Children with Acute Lymphoblastic Leukemia
BT  - Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022)
PB  - Atlantis Press
SP  - 210
EP  - 221
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-070-1_26
DO  - 10.2991/978-94-6463-070-1_26
ID  - Alfiyanti2022
ER  -